Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520.
(Q44931220)
scientific article
scientific article
Language:
| (P31) |
(Q13442814)
|
||||||||||||||||
| (P50) |
(Q89926093)
|
||||||||||||||||
| (P304) |
38-45
|
||||||||||||||||
| (P407) |
(Q1860)
|
||||||||||||||||
| (P433) |
1
|
||||||||||||||||
| (P478) |
54
|
||||||||||||||||
| (P577) |
Wednesday, June 9, 2004
|
||||||||||||||||
| (P921) |
(Q310443)
|
||||||||||||||||
| (P1433) |
(Q6294770)
|
||||||||||||||||
| (P1476) |
"Substitution of threonine-1351 in the multidrug transporter Cdr1p of Candida albicans results in hypersusceptibility to antifungal agents and threonine-1351 is essential for synergic effects of calcineurin inhibitor FK520." (language: en)
|
||||||||||||||||
| (P2093) |
Suneet Shukla
Suresh V Ambudkar
|
other details